Psoriatic arthritis - continuing authority application form (PB106)

Use this form to apply to continue PBS-subsidised treatment with a biological agent for adult patients with psoriatic arthritis.

'Biological agent' refers to:

  • adalimumab
  • certolizumab pegol
  • etanercept
  • golimumab
  • guselkumab
  • infliximab
  • ixekizumab
  • secukinumab
  • tofacitinib
  • upadacitinib
  • ustekinumab.

Download and complete the psoriatic arthritis - continuing authority application form.

To fill in this form digitally you will need a computer and Adobe Acrobat Reader, or a similar program. You can download Adobe Acrobat Reader for free. If you can’t complete the form digitally, you can print it, complete it by hand and return it to us following the instructions on the form.

You can upload this form in HPOS.

If you have a disability or impairment and use assistive technology, you may not be able to access our forms. If you can’t, please contact us. We can help you access, complete and submit them.

Page last updated: 17 November 2022.
QC 21111